HKSE •
Healthcare •
Biotechnology •
Quote as of 07/29/2026 16:08
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization3,698.74 mln
Float85.59 mln
Earnings Date08/22/2026
EPS
1.25
Decent
P / E
13.15
Fair value
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.38
Borderline
Relative Strength
50
/ 100
In line with market
Debt / Equity
0.06
Debt-free
Business Description
Shanghai Haohai Biological Technology is a China-based company founded in 2007 that develops, manufactures, and sells a broad range of medical and biomedical products across China, Europe, the United States, and other markets. Its core offerings include eye care devices such as intraocular lenses and surgical instruments, as well as materials like hyaluronic acid used in both medical and skincare applications. The company also produces electronic and optical instruments, biological reagents, and contact lens accessories, while providing supporting services such as technology consulting, trade, and business management.